HIGHLIGHTS
- who: VEGFR and colleagues from the Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China have published the research work: Adropin Improves Radiation-Induced Myocardial Injury via VEGFR2/PI3K/Akt Pathway, in the Journal: Oxidative Medicine and Cellular Longevity of 29/06/2022
- what: In this study the regulatory role of adropin (Ad) in radiation-induced myocardial injury (RIMI) was explored in mice.
- how: The results showed that exogenous Ad effectively improved cardiac function suppressed oxidative stress inhibited myocardial fibrosis reduced myocardial apoptosis and promoted microangiogenesis in RIMI . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.